Epidemiology and global burden of infective endocarditis
Infective endocarditis (IE) is still considered to be an infrequent but fatal and debilitating disease if left untreated. It is estimated that IE affects 3–7.5 people per 100,000 person-years and its incidence is reported to be increasing in some parts of the world. IE incidence appears to vary significantly as reported from different geographic areas even within the same country. IE is a disabling and lethal disease with an overall mean proportion of IE-related stroke of 15.8% ± 9.1%, a mean proportion of patients that have undergone valve surgery of 32.4% ± 18.8%, and a mean case fatality risk of 21.1% ± 10.4%. IE incidence remains largely unknown from many parts of the world due to a paucity of data from several countries. Intravenous drug use, advanced age, intracardiac electronic devices, degenerative valvular heart disease, cardiac transplant with development of valvulopathy, haemodialysis, HIV infection, and diabetes mellitus are among the new emerging risk factors that have recently been shown to be implicated more frequently than the traditional risk factors in IE development. Staphylococcus aureus is the leading cause of IE worldwide and has taken predominance over viridans group streptococci in many parts of the world. Globally, IE is associated with a significant burden and was responsible for 45,000 deaths in 1990 and 65,000 deaths in 2013. The mortality rate from IE is significantly high, with an in-hospital mortality rate of up to 22% and a 5-year mortality rate of 45%.